In a non‐life‐threatening disease such as psoriasis, treatment goals should be referred to
the improvement in severity and extent of the disease and their impact on patients' perceived …

Objective Cost per quality-adjusted life year data are required for reimbursement decisions
in many Central and Eastern European (CEE) countries. EQ-5D is by far the most commonly …

Psoriasis has been shown to be associated with an increased prevalence of comorbid major
depression. IL-17A plays an important role in both depression and psoriasis. IL-17A has …

Background Hidradenitis suppurativa (HS) has a major impact on patients' quality of life
(QoL). Although it has commonly been assumed that HS impairs sexual health, only a single …

Background Though patient needs are key drivers of treatment decisions, they are rarely
systematically investigated in routine care. Objective This study aimed at analysing needs …

Background Mapping is an increasingly common method used to predict instrument-specific
preference-based health-state utility values (HSUVs) from data obtained from another health …

Summary Background 'Not relevant'responses (NRRs) on the Dermatology Life Quality
Index (DLQI) may occur in up to 40% of patients with psoriasis. As these responses are …

Abstract Background Dermatology Life Quality Index (DLQI) is the most common health‐
related quality of life measure in dermatology that is widely used in treatment guidelines for …

The purpose of this study is to assess the measurement properties of EQ-5D-5L compared to
EQ-5D-3L in psoriasis patients. Methods A cross-sectional survey was carried out at an …

The advances in psoriasis management currently allow achieving a good control of the
disease. In particular, with the latest developed molecules, available evidence suggests that …